CC
The Chemours Company
Price Chart
Latest Quote
$21.77
| Previous Close | $22.02 |
| Open | $22.27 |
| Day High | $22.33 |
| Day Low | $21.62 |
| Volume | 1,392,806 |
Stock Information
| Shares Outstanding | 150.38M |
| Total Debt | $4.39B |
| Cash Equivalents | $563.00M |
| Revenue | $5.82B |
| Net Income | $-410.00M |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Market Cap | $3.27B |
| EPS (TTM) | $-2.73 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $7.09B |
| Sales | $5.82B |
| Income | $-410.00M |
| Book/sh | $1.43 |
| Cash/sh | $3.74 |
| Employees | 6K |
Financial Ratios
| Quick Ratio | 0.82 |
| Current Ratio | 1.82 |
| Debt/Eq | 2033.80 |
Returns & Margins
| ROA | 2.13% |
| ROE | -103.01% |
| Gross Margin | 15.20% |
| Operating Margin | 2.97% |
| Profit Margin | -7.04% |
Ownership
| Insider Ownership | 0.36% |
| Institutional Ownership | 88.59% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 9.63 |
| PEG | 1.60 |
| P/S | 0.56 |
| P/B | 15.22 |
Analyst Data
| Recommendation | buy |
| Target Price | $26.33 |
Technical Indicators
| SMA20 | $21.77 |
| SMA50 | $23.26 |
| SMA200 | $17.30 |
| RSI | 47.68 |
| ATR | 1.1598 |
| Shares Float | 149.95M |
| Short Float | 8.68% |
| Short Ratio | 2.96 |
| Volatility | 1.39 |
| Rel Volume | 1.16 |
Performance History
| Week | +1.16% |
| Month | +0.09% |
| Quarter | +15.35% |
| 6 Months | +87.84% |
| YTD | +79.26% |
| Year | +107.15% |
| 3 Years | -24.76% |
| 5 Years | -31.10% |
| 10 Years | +227.74% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $21.77 | 2,477,200 |
| 2026-06-17 | $22.02 | 1,977,300 |
| 2026-06-16 | $21.67 | 2,392,000 |
| 2026-06-15 | $22.43 | 2,231,200 |
| 2026-06-12 | $22.00 | 1,223,800 |
| 2026-06-11 | $21.52 | 1,564,900 |
| 2026-06-10 | $20.31 | 1,884,700 |
| 2026-06-09 | $20.22 | 3,847,400 |
| 2026-06-08 | $20.86 | 1,175,400 |
| 2026-06-05 | $20.50 | 2,185,400 |
| 2026-06-04 | $21.67 | 2,410,900 |
| 2026-06-03 | $22.61 | 1,509,000 |
| 2026-06-02 | $23.25 | 1,853,800 |
| 2026-06-01 | $22.32 | 2,355,500 |
| 2026-05-29 | $22.16 | 1,921,200 |
| 2026-05-28 | $22.72 | 2,019,100 |
| 2026-05-27 | $22.50 | 2,304,200 |
| 2026-05-26 | $22.10 | 2,173,500 |
| 2026-05-22 | $21.37 | 2,042,200 |
| 2026-05-21 | $21.44 | 3,318,800 |
| 2026-05-20 | $22.27 | 1,703,100 |
| 2026-05-19 | $21.75 | 4,166,000 |
About The Chemours Company
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
đ° Latest News
Chemours (CC) Down 4.5% Since Last Earnings Report: Can It Rebound?
Zacks âĸ 2026-06-04T15:30:10ZTrumpâs Manufacturing Push Is Creating Tailwinds for These 3 Stocks Under $30
24/7 Wall St. âĸ 2026-05-15T16:19:19ZDo These 3 Checks Before Buying The Chemours Company (NYSE:CC) For Its Upcoming Dividend
Simply Wall St. âĸ 2026-05-11T13:29:11ZChemours Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-09T17:12:41ZResults: The Chemours Company Delivered A Surprise Loss And Now Analysts Have New Forecasts
Simply Wall St. âĸ 2026-05-08T13:39:04ZChemours' Q1 Earnings Surpass Estimates, Revenues Miss
Zacks âĸ 2026-05-07T12:06:00ZChemours (CC) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-06T19:24:51ZThe Chemours Company Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-06T12:30:00ZChemours (CC) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks âĸ 2026-05-05T23:00:03ZAlta Fundamental Dumps 175K Chemours Shares in Q1
Motley Fool âĸ 2026-05-05T21:32:03ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $4,906,000,000 | $4,640,000,000 | $4,776,000,000 | $5,215,000,000 |
| Cost Of Revenue | $4,906,000,000 | $4,640,000,000 | $4,776,000,000 | $5,215,000,000 |
| Total Revenue | $5,808,000,000 | $5,782,000,000 | $6,078,000,000 | $6,831,000,000 |
| Operating Revenue | $5,808,000,000 | $5,782,000,000 | $6,078,000,000 | $6,831,000,000 |
| Expenses | ||||
| Interest Expense | $269,000,000 | $263,000,000 | $208,000,000 | $163,000,000 |
| Total Expenses | $5,836,000,000 | $5,361,000,000 | $6,201,000,000 | $6,045,000,000 |
| Other Income Expense | $20,000,000 | $-52,000,000 | $13,000,000 | $118,000,000 |
| Other Non Operating Income Expenses | $29,000,000 | $14,000,000 | $19,000,000 | $64,000,000 |
| Net Non Operating Interest Income Expense | $-269,000,000 | $-263,000,000 | $-208,000,000 | $-163,000,000 |
| Interest Expense Non Operating | $269,000,000 | $263,000,000 | $208,000,000 | $163,000,000 |
| Operating Expense | $930,000,000 | $721,000,000 | $1,425,000,000 | $830,000,000 |
| Other Operating Expenses | $23,000,000 | $14,000,000 | $31,000,000 | $2,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-386,000,000 | $69,000,000 | $-253,000,000 | $578,000,000 |
| Net Interest Income | $-269,000,000 | $-263,000,000 | $-208,000,000 | $-163,000,000 |
| Normalized Income | $-351,240,000 | $139,959,000 | $-212,608,000 | $578,780,000 |
| Net Income From Continuing And Discontinued Operation | $-386,000,000 | $69,000,000 | $-253,000,000 | $578,000,000 |
| Net Income Common Stockholders | $-386,000,000 | $69,000,000 | $-253,000,000 | $578,000,000 |
| Net Income | $-386,000,000 | $69,000,000 | $-253,000,000 | $578,000,000 |
| Net Income Including Noncontrolling Interests | $-386,000,000 | $69,000,000 | $-252,000,000 | $578,000,000 |
| Net Income Continuous Operations | $-386,000,000 | $69,000,000 | $-252,000,000 | $578,000,000 |
| Pretax Income | $-277,000,000 | $106,000,000 | $-318,000,000 | $741,000,000 |
| Special Income Charges | $-33,000,000 | $-100,000,000 | $-13,000,000 | $14,000,000 |
| Earnings From Equity Interest | $35,000,000 | $43,000,000 | $45,000,000 | $55,000,000 |
| Operating Income | $-28,000,000 | $421,000,000 | $-123,000,000 | $786,000,000 |
| Gross Profit | $902,000,000 | $1,142,000,000 | $1,302,000,000 | $1,616,000,000 |
| Per Share | ||||
| Diluted EPS | $-2.57 | $0.57 | $-1.70 | $3.65 |
| Basic EPS | $-2.57 | $0.58 | $-1.70 | $3.72 |
| Other | ||||
| Tax Effect Of Unusual Items | $-9,240,000 | $-38,041,000 | $-10,608,000 | $-220,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $376,000,000 | $770,000,000 | $250,000,000 | $1,196,000,000 |
| Total Unusual Items | $-44,000,000 | $-109,000,000 | $-51,000,000 | $-1,000,000 |
| Total Unusual Items Excluding Goodwill | $-44,000,000 | $-109,000,000 | $-51,000,000 | $-1,000,000 |
| Reconciled Depreciation | $340,000,000 | $292,000,000 | $309,000,000 | $291,000,000 |
| EBITDA (Bullshit earnings) | $332,000,000 | $661,000,000 | $199,000,000 | $1,195,000,000 |
| EBIT | $-8,000,000 | $369,000,000 | $-110,000,000 | $904,000,000 |
| Diluted Average Shares | $150,641,882 | $150,172,289 | $148,912,397 | $158,303,007 |
| Basic Average Shares | $150,237,101 | $149,494,462 | $148,912,397 | $150,046,614 |
| Diluted NI Availto Com Stockholders | $-386,000,000 | $69,000,000 | $-253,000,000 | $578,000,000 |
| Minority Interests | $0 | $0 | $-1,000,000 | $0 |
| Tax Provision | $109,000,000 | $37,000,000 | $-66,000,000 | $163,000,000 |
| Gain On Sale Of Ppe | $8,000,000 | $3,000,000 | $110,000,000 | $21,000,000 |
| Other Special Charges | $5,000,000 | $1,000,000 | $1,000,000 | $-7,000,000 |
| Impairment Of Capital Assets | $0 | $56,000,000 | $0 | $0 |
| Restructuring And Mergern Acquisition | $36,000,000 | $46,000,000 | $122,000,000 | $14,000,000 |
| Gain On Sale Of Security | $-11,000,000 | $-9,000,000 | $-38,000,000 | $-15,000,000 |
| Research And Development | $108,000,000 | $109,000,000 | $108,000,000 | $118,000,000 |
| Selling General And Administration | $799,000,000 | $598,000,000 | $1,286,000,000 | $710,000,000 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $202,000,000 | $522,000,000 | $632,000,000 | $992,000,000 |
| Total Assets | $7,382,000,000 | $7,509,000,000 | $8,251,000,000 | $7,640,000,000 |
| Total Non Current Assets | $4,381,000,000 | $4,492,000,000 | $4,416,000,000 | $4,426,000,000 |
| Other Non Current Assets | $428,000,000 | $461,000,000 | $317,000,000 | $523,000,000 |
| Non Current Deferred Assets | $254,000,000 | $280,000,000 | $303,000,000 | $152,000,000 |
| Non Current Deferred Taxes Assets | $254,000,000 | $280,000,000 | $303,000,000 | $152,000,000 |
| Goodwill And Other Intangible Assets | $48,000,000 | $49,000,000 | $105,000,000 | $115,000,000 |
| Other Intangible Assets | $2,000,000 | $3,000,000 | $3,000,000 | $13,000,000 |
| Current Assets | $3,001,000,000 | $3,017,000,000 | $3,835,000,000 | $3,214,000,000 |
| Other Current Assets | $80,000,000 | $71,000,000 | $66,000,000 | $82,000,000 |
| Assets Held For Sale Current | $1,000,000 | $0 | - | - |
| Restricted Cash | $2,000,000 | $0 | $604,000,000 | $0 |
| Inventory | $1,569,000,000 | $1,463,000,000 | $1,352,000,000 | $1,404,000,000 |
| Receivables | $679,000,000 | $770,000,000 | $610,000,000 | $626,000,000 |
| Other Receivables | $21,000,000 | $37,000,000 | $20,000,000 | $29,000,000 |
| Taxes Receivable | $96,000,000 | $114,000,000 | $81,000,000 | $88,000,000 |
| Accounts Receivable | $562,000,000 | $619,000,000 | $509,000,000 | $509,000,000 |
| Allowance For Doubtful Accounts Receivable | $-2,000,000 | $-2,000,000 | $-2,000,000 | $-10,000,000 |
| Gross Accounts Receivable | $564,000,000 | $621,000,000 | $511,000,000 | $519,000,000 |
| Cash Cash Equivalents And Short Term Investments | $670,000,000 | $713,000,000 | $1,203,000,000 | $1,102,000,000 |
| Cash And Cash Equivalents | $670,000,000 | $713,000,000 | $1,203,000,000 | $1,102,000,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $3,471,000,000 | $3,400,000,000 | $2,835,000,000 | $2,531,000,000 |
| Total Debt | $4,394,000,000 | $4,367,000,000 | $4,299,000,000 | $3,880,000,000 |
| Long Term Debt And Capital Lease Obligation | $4,290,000,000 | $4,257,000,000 | $4,193,000,000 | $3,788,000,000 |
| Long Term Debt | $4,099,000,000 | $4,059,000,000 | $3,987,000,000 | $3,590,000,000 |
| Current Debt And Capital Lease Obligation | $104,000,000 | $110,000,000 | $106,000,000 | $92,000,000 |
| Current Debt | $42,000,000 | $54,000,000 | $51,000,000 | $43,000,000 |
| Other Current Borrowings | $42,000,000 | $54,000,000 | $51,000,000 | $43,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,131,000,000 | $6,937,000,000 | $7,512,000,000 | $6,533,000,000 |
| Total Non Current Liabilities Net Minority Interest | $5,445,000,000 | $5,117,000,000 | $5,026,000,000 | $4,642,000,000 |
| Other Non Current Liabilities | $122,000,000 | $115,000,000 | $113,000,000 | $109,000,000 |
| Non Current Deferred Liabilities | $37,000,000 | $35,000,000 | $44,000,000 | $61,000,000 |
| Non Current Deferred Taxes Liabilities | $37,000,000 | $35,000,000 | $44,000,000 | $61,000,000 |
| Current Liabilities | $1,686,000,000 | $1,820,000,000 | $2,486,000,000 | $1,891,000,000 |
| Payables And Accrued Expenses | $1,389,000,000 | $1,488,000,000 | $2,144,000,000 | $1,474,000,000 |
| Interest Payable | $33,000,000 | $18,000,000 | $18,000,000 | $17,000,000 |
| Payables | $964,000,000 | $1,178,000,000 | $1,187,000,000 | $1,252,000,000 |
| Total Tax Payable | $35,000,000 | $44,000,000 | $53,000,000 | $42,000,000 |
| Income Tax Payable | $10,000,000 | $22,000,000 | $28,000,000 | $19,000,000 |
| Accounts Payable | $929,000,000 | $1,134,000,000 | $1,134,000,000 | $1,210,000,000 |
| Other Current Liabilities | - | - | - | $90,000,000 |
| Current Deferred Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $250,000,000 | $571,000,000 | $737,000,000 | $1,107,000,000 |
| Total Equity Gross Minority Interest | $251,000,000 | $572,000,000 | $739,000,000 | $1,107,000,000 |
| Stockholders Equity | $250,000,000 | $571,000,000 | $737,000,000 | $1,107,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-244,000,000 | $-367,000,000 | $-274,000,000 | $-343,000,000 |
| Other Equity Adjustments | $-244,000,000 | $-367,000,000 | $-274,000,000 | $-343,000,000 |
| Retained Earnings | $1,220,000,000 | $1,685,000,000 | $1,782,000,000 | $2,170,000,000 |
| Long Term Equity Investment | $160,000,000 | $152,000,000 | $158,000,000 | $175,000,000 |
| Investments In Other Ventures Under Equity Method | - | - | - | $175,000,000 |
| Other | ||||
| Treasury Shares Number | $48,826,793 | $48,871,602 | $48,932,387 | $46,871,780 |
| Ordinary Shares Number | $149,893,993 | $149,428,431 | $148,587,397 | $148,504,030 |
| Share Issued | $198,720,786 | $198,300,033 | $197,519,784 | $195,375,810 |
| Tangible Book Value | $202,000,000 | $522,000,000 | $632,000,000 | $992,000,000 |
| Invested Capital | $4,391,000,000 | $4,684,000,000 | $4,775,000,000 | $4,740,000,000 |
| Working Capital | $1,315,000,000 | $1,197,000,000 | $1,349,000,000 | $1,323,000,000 |
| Capital Lease Obligations | $253,000,000 | $254,000,000 | $261,000,000 | $247,000,000 |
| Total Capitalization | $4,349,000,000 | $4,630,000,000 | $4,724,000,000 | $4,697,000,000 |
| Minority Interest | $1,000,000 | $1,000,000 | $2,000,000 | $0 |
| Treasury Stock | $1,802,000,000 | $1,804,000,000 | $1,806,000,000 | $1,738,000,000 |
| Additional Paid In Capital | $1,074,000,000 | $1,055,000,000 | $1,033,000,000 | $1,016,000,000 |
| Capital Stock | $2,000,000 | $2,000,000 | $2,000,000 | $2,000,000 |
| Common Stock | $2,000,000 | $2,000,000 | $2,000,000 | $2,000,000 |
| Employee Benefits | $58,000,000 | $65,000,000 | $75,000,000 | $82,000,000 |
| Non Current Accrued Expenses | $317,000,000 | $96,000,000 | $73,000,000 | $55,000,000 |
| Long Term Capital Lease Obligation | $191,000,000 | $198,000,000 | $206,000,000 | $198,000,000 |
| Long Term Provisions | $621,000,000 | $549,000,000 | $528,000,000 | $547,000,000 |
| Current Capital Lease Obligation | $62,000,000 | $56,000,000 | $55,000,000 | $49,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $96,000,000 | $99,000,000 | $89,000,000 | $121,000,000 |
| Current Provisions | $97,000,000 | $123,000,000 | $147,000,000 | $204,000,000 |
| Current Accrued Expenses | $425,000,000 | $310,000,000 | $957,000,000 | $222,000,000 |
| Defined Pension Benefit | $142,000,000 | $97,000,000 | $57,000,000 | $50,000,000 |
| Investments And Advances | $160,000,000 | $152,000,000 | $158,000,000 | $175,000,000 |
| Goodwill | $46,000,000 | $46,000,000 | $102,000,000 | $102,000,000 |
| Net PPE | $3,349,000,000 | $3,453,000,000 | $3,476,000,000 | $3,411,000,000 |
| Accumulated Depreciation | $-6,842,000,000 | $-6,389,000,000 | $-6,196,000,000 | $-6,216,000,000 |
| Gross PPE | $10,191,000,000 | $9,842,000,000 | $9,672,000,000 | $9,627,000,000 |
| Construction In Progress | $319,000,000 | $404,000,000 | $450,000,000 | $324,000,000 |
| Other Properties | $8,585,000,000 | $8,181,000,000 | $7,912,000,000 | $7,985,000,000 |
| Buildings And Improvements | $1,187,000,000 | $1,133,000,000 | $1,180,000,000 | $1,180,000,000 |
| Land And Improvements | $69,000,000 | $88,000,000 | $94,000,000 | $102,000,000 |
| Properties | $31,000,000 | $36,000,000 | $36,000,000 | $36,000,000 |
| Inventories Adjustments Allowances | $-368,000,000 | $-376,000,000 | $-382,000,000 | $-378,000,000 |
| Finished Goods | $875,000,000 | $889,000,000 | $770,000,000 | $910,000,000 |
| Work In Process | $259,000,000 | $271,000,000 | $255,000,000 | $218,000,000 |
| Raw Materials | $803,000,000 | $679,000,000 | $709,000,000 | $654,000,000 |
| Investmentsin Associatesat Cost | - | - | - | $175,000,000 |
| Non Current Deferred Revenue | - | - | - | - |
| Current Deferred Revenue | - | - | - | - |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $51,000,000 | $-993,000,000 | $186,000,000 | $448,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $264,000,000 | $-633,000,000 | $556,000,000 | $755,000,000 |
| Cash Flow From Continuing Operating Activities | $264,000,000 | $-633,000,000 | $556,000,000 | $755,000,000 |
| Operating Gains Losses | $-12,000,000 | $3,000,000 | $-89,000,000 | $-41,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-213,000,000 | $-360,000,000 | $-370,000,000 | $-307,000,000 |
| Investing Cash Flow | $-206,000,000 | $-353,000,000 | $-229,000,000 | $-284,000,000 |
| Cash Flow From Continuing Investing Activities | $-206,000,000 | $-353,000,000 | $-229,000,000 | $-284,000,000 |
| Net Other Investing Changes | $8,000,000 | $5,000,000 | $149,000,000 | $20,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $0 | $-69,000,000 | $-495,000,000 |
| Financing Cash Flow | $-126,000,000 | $-36,000,000 | $172,000,000 | $-686,000,000 |
| Cash Flow From Continuing Financing Activities | $-126,000,000 | $-36,000,000 | $172,000,000 | $-686,000,000 |
| Net Other Financing Charges | $13,000,000 | $8,000,000 | $-22,000,000 | $-8,000,000 |
| Cash Dividends Paid | $-78,000,000 | $-148,000,000 | $-149,000,000 | $-154,000,000 |
| Common Stock Dividend Paid | $-78,000,000 | $-148,000,000 | $-149,000,000 | $-154,000,000 |
| Net Common Stock Issuance | $0 | $0 | $-69,000,000 | $-495,000,000 |
| Other | ||||
| Repayment Of Debt | $-889,000,000 | $-604,000,000 | $-378,000,000 | $-185,000,000 |
| Issuance Of Debt | $828,000,000 | $699,000,000 | $771,000,000 | $105,000,000 |
| Interest Paid Supplemental Data | $251,000,000 | $267,000,000 | $223,000,000 | $164,000,000 |
| Income Tax Paid Supplemental Data | $74,000,000 | $82,000,000 | $63,000,000 | $131,000,000 |
| End Cash Position | $724,000,000 | $763,000,000 | $1,807,000,000 | $1,304,000,000 |
| Beginning Cash Position | $763,000,000 | $1,807,000,000 | $1,304,000,000 | $1,551,000,000 |
| Effect Of Exchange Rate Changes | $29,000,000 | $-22,000,000 | $4,000,000 | $-32,000,000 |
| Changes In Cash | $-68,000,000 | $-1,022,000,000 | $499,000,000 | $-215,000,000 |
| Proceeds From Stock Option Exercised | $0 | $9,000,000 | $19,000,000 | $51,000,000 |
| Common Stock Payments | $0 | $0 | $-69,000,000 | $-495,000,000 |
| Net Issuance Payments Of Debt | $-61,000,000 | $95,000,000 | $393,000,000 | $-80,000,000 |
| Net Long Term Debt Issuance | $-61,000,000 | $95,000,000 | $393,000,000 | $-80,000,000 |
| Long Term Debt Payments | $-889,000,000 | $-604,000,000 | $-378,000,000 | $-185,000,000 |
| Long Term Debt Issuance | $828,000,000 | $699,000,000 | $771,000,000 | $105,000,000 |
| Net Investment Purchase And Sale | $-1,000,000 | $2,000,000 | $-8,000,000 | $3,000,000 |
| Net PPE Purchase And Sale | $-213,000,000 | $-360,000,000 | $-370,000,000 | $-307,000,000 |
| Purchase Of PPE | $-213,000,000 | $-360,000,000 | $-370,000,000 | $-307,000,000 |
| Change In Working Capital | $178,000,000 | $-1,022,000,000 | $618,000,000 | $-103,000,000 |
| Change In Other Current Liabilities | $277,000,000 | $-649,000,000 | $645,000,000 | $91,000,000 |
| Change In Other Current Assets | $66,000,000 | $-98,000,000 | $0 | $-96,000,000 |
| Change In Payables And Accrued Expense | $-165,000,000 | $4,000,000 | $-74,000,000 | $105,000,000 |
| Change In Payable | $-165,000,000 | $4,000,000 | $-74,000,000 | $105,000,000 |
| Change In Account Payable | $-165,000,000 | $4,000,000 | $-74,000,000 | $105,000,000 |
| Change In Inventory | $-106,000,000 | $-140,000,000 | $61,000,000 | $-294,000,000 |
| Change In Receivables | $106,000,000 | $-139,000,000 | $-14,000,000 | $91,000,000 |
| Other Non Cash Items | $59,000,000 | $-15,000,000 | $95,000,000 | $-17,000,000 |
| Stock Based Compensation | $21,000,000 | $15,000,000 | $18,000,000 | $27,000,000 |
| Asset Impairment Charge | $0 | $56,000,000 | $0 | $0 |
| Deferred Tax | $64,000,000 | $-31,000,000 | $-143,000,000 | $20,000,000 |
| Deferred Income Tax | $64,000,000 | $-31,000,000 | $-143,000,000 | $20,000,000 |
| Depreciation Amortization Depletion | $340,000,000 | $292,000,000 | $309,000,000 | $291,000,000 |
| Depreciation And Amortization | $340,000,000 | $292,000,000 | $309,000,000 | $291,000,000 |
| Depreciation | $340,000,000 | $301,000,000 | $297,000,000 | $286,000,000 |
| Pension And Employee Benefit Expense | $-2,000,000 | $6,000,000 | $9,000,000 | $9,000,000 |
| Earnings Losses From Equity Investments | $-7,000,000 | $-1,000,000 | $11,000,000 | $-22,000,000 |
| Net Income From Continuing Operations | $-386,000,000 | $69,000,000 | $-252,000,000 | $578,000,000 |
| Amortization Cash Flow | - | $1,000,000 | $10,000,000 | $5,000,000 |
| Amortization Of Intangibles | - | $1,000,000 | $10,000,000 | $5,000,000 |
| Net Short Term Debt Issuance | - | - | - | $0 |
| Short Term Debt Payments | - | - | - | $0 |
| Short Term Debt Issuance | - | - | - | $0 |
| Purchase Of Investment | - | - | - | - |
| Net Business Purchase And Sale | - | - | - | - |
| Purchase Of Business | - | - | - | - |